Catastrophic antiphospholipid syndrome complicated by cardiogenic shock - A case report;Katastroficzny zespół antyfosfolipidowy przebiegaja̧cy ze wstrza̧sem kardiogennym - Opis przypadku

Kardiologia Polska

Volumn 67, Issue 7, 2009, Pages 769-773

  Ziȩba, Bozena ^a   Wȩgrzyn, Agnieszka ^a   Mital, Andrzej ^a   Szczepińska Nowak, Maria ^b   Lewicki, Łukasz ^a   Chmielecki, Michał ^a   Puchalski, Wiesław ^a   Rynkiewicz, Andrzej ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b Szpital Specjalistyczny Im W Adalberta   (Poland)

Author keywords

Cardiogenic shock; Catastrophic antiphospholipid syndrome; Systemic lupus erythematosus

Indexed keywords

ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; CARVEDILOL; CYCLOPHOSPHAMIDE; DIGOXIN; DOBUTAMINE; DOPAMINE; IMMUNOGLOBULIN; LUPUS ANTICOAGULANT; METHYLPREDNISOLONE; NORADRENALIN; OMEPRAZOLE; PREDNISONE; RAMIPRIL; STEROID;

ACUTE HEART FAILURE; ACUTE KIDNEY FAILURE; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CARDIOGENIC SHOCK; CARDIOMYOPATHY; CASE REPORT; CYTOMEGALY; DELIVERY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LABORATORY TEST; NEUROLOGIC DISEASE; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 68149170493     PISSN: 00229032     EISSN: 00229032     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Asherson RA. The catastrophic antiphospholipid antibody syndrome. J Rheumatol 1992; 19: 508-512
2. Asherson RA, Cervera R, Piette JC, et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355. (Pubitemid 33070843)
3. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295.
4. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309. (Pubitemid 30265586)
5. Reber G, Tincani A, Sanmarco M, et al. Proposals for the measurement of anti-beta2-glycoprotein I antibodies. Standardization group of the European Forum on Antiphospholipid Antibodies. J Thromb Haemost 2004; 2: 1860. (Pubitemid 40192732)
6. Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019. (Pubitemid 34303815)
7. Erkan D, Lockshin MD. What is antiphospholipid syndrome? Curr Rheumatol Rep 2004; 6: 451.
8. Merrill JT, Asherson RA. Catastrophic antiphospholipid syndrome. Nat Clin Pract Rheumatol 2006; 2: 81-89
9. Vora SK, Asherson RA, Erkan D. Catastrophic antiphospholipid syndrome. J Intensive Care Med 2006; 21: 144-159
10. Asherson RA, Espinosa G, Cervera R, et al. Disseminated intravascular coagulation in catastrophic antiphospholipid syndrome: clinical and haematological characteristics of 23 patients. Ann Rheum Dis 2005; 64: 943-946 (Pubitemid 40733924)
11. Goodnight SH. Antiphospholipid antibodies and thrombosis. Curr Opin Hematol 1994; 1: 354.
12. Prokop J, Witkowski M, Musiał W, et al. Zawał serca u 24-letniej chorej z wtórnym zespołem antyfosfolipidowym. Kardiol Pol 2004; 61: 367-369
13. Wieteska M, Szturmowicz M, Kurzyna M, et al. Powikłania naczyniowe u 51-letniej chorej z pierwotnym zespołem antyfosfolipidowym - opis przypadku. Kardiol Pol 2007; 65: 50-53